Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MTTI-Next
- Development stage
- Preclinical
- Lead developer
- Molecular Targeting Technologies
- Modality
- Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
MTTI-Next is a preclinical-stage targeted radiotherapeutic (TRT) being developed by Molecular Targeting Technologies (MTTI). As a radiopharmaceutical, it is designed to deliver therapeutic ionizing radiation specifically to diseased cells by utilizing a targeting moiety conjugated to a radioisotope. While the specific molecular target and primary indications for MTTI-Next have not been publicly disclosed, it represents a next-generation asset in MTTI's pipeline of radiotheranostic agents, which focuses on precision oncology and the treatment of various malignancies such as neuroendocrine tumors and prostate cancer.
Beyond the preview
Go deeper on MTTI-Next.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MTTI-Next.